chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Shoulder injury related to vaccine administration, Vaccination site induration, Vaccination site pain
Clinical narrative: I experienced a painful knot in theright arm muscle where the COVIDvaccine was injected.; lost strength in right arm; I experience pain when I getdressed, and do simple things likereach for a dish from the cabinet.; the pain when I use that arm is now in my shoulder.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021(at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications included vitamins and immune support supplement both from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 01Mar2021(at the age of 70-years-old) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced painful knot in the right arm muscle where the COVID vaccine was injected. The patient lost strength in her right arm, which continued to be weak. The patient experienced pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder. No therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events painful knot in the right arm muscle where the COVID vaccine was injected, lost strength in her right arm, which continued to be weak, pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Pain in extremity, Vaccination site pain
Clinical narrative: I experienced a painful knot in theright arm muscle where the COVIDvaccine was injected.; lost strength in right arm; I experience pain when I getdressed, and do simple things likereach for a dish from the cabinet.; the pain when I use that arm is now in my shoulder.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021(at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications included vitamins and immune support supplement both from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 01Mar2021(at the age of 70-years-old) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced painful knot in the right arm muscle where the COVID vaccine was injected. The patient lost strength in her right arm, which continued to be weak. The patient experienced pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder. No therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events painful knot in the right arm muscle where the COVID vaccine was injected, lost strength in her right arm, which continued to be weak, pain when she got dressed, and while doing simple things like reach for a dish from the cabinet and the pain when she used that arm was in her shoulder was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; minor Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on the left arm on 13Apr2021 at 11:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food or other products. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19 The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 17:30, the patient experienced minor fatigue started about 6 hours after the injection and stayed for approximately 24 hours. Headache started about 6 hours after injection and got progressively worse for the next 3 hours. On 13Apr2021 at 19:30, nausea started about 8 hours after injection and led to vomiting. After vomiting, nausea and headache subsided for a few hours and then came back. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with ibuprofen from a unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events minor fatigue, headache, vomiting and nausea was recovered on an unknown date in Apr 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cystitis, Diarrhoea, Headache, Muscle spasms, Pyrexia
Clinical narrative: Muscle spasms; numbness; tingling; fever; headache; UTI; Bladder infection; diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 11:00 (Age at vaccination: 35 years) as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, migraine and chronic fatigue. The patient's concomitant medications were not reported. Patient did not receive other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced muscle spasms, numbness, tingling, fever, headache, uti (urinary tract infection), bladder infection (cystitis) and diarrhea on 09Apr2021 at 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Apr2021. The patient received Bactrim for UTI. Patient had physician office visit. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: Muscle spasms; numbness; tingling; fever; headache; UTI; Bladder infection; diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 11:00 (Age at vaccination: 35 years) as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, migraine and chronic fatigue. The patient's concomitant medications were not reported. Patient did not receive other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced muscle spasms, numbness, tingling, fever, headache, uti (urinary tract infection), bladder infection (cystitis) and diarrhea on 09Apr2021 at 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Apr2021. The patient received Bactrim for UTI. Patient had physician office visit. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cystitis, Diarrhoea, Headache, Hypoaesthesia, Muscle spasms
Clinical narrative: Muscle spasms; numbness; tingling; fever; headache; UTI; Bladder infection; diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 11:00 (Age at vaccination: 35 years) as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, migraine and chronic fatigue. The patient's concomitant medications were not reported. Patient did not receive other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced muscle spasms, numbness, tingling, fever, headache, uti (urinary tract infection), bladder infection (cystitis) and diarrhea on 09Apr2021 at 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Apr2021. The patient received Bactrim for UTI. Patient had physician office visit. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pyrexia, SARS-CoV-2 test, Urinary tract infection
Clinical narrative: Muscle spasms; numbness; tingling; fever; headache; UTI; Bladder infection; diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 35-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 11:00 (Age at vaccination: 35 years) as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, migraine and chronic fatigue. The patient's concomitant medications were not reported. Patient did not receive other vaccines in 4 weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced muscle spasms, numbness, tingling, fever, headache, uti (urinary tract infection), bladder infection (cystitis) and diarrhea on 09Apr2021 at 15:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Apr2021. The patient received Bactrim for UTI. Patient had physician office visit. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cough, Headache, Pyrexia
Clinical narrative: cough; weakness; Fever; headache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6207) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer, hypertrophic cardiomyopathy, ceohalosporins allergy, ampicilln allergy, sulfa antibiotics allergy and anemia. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), simvastatin (MANUFACTURER UNKNOWN), apixaban (ELIQUIS), levothyroxine (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 25Mar2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced cough, weakness, fever and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event cough, weakness, fever and headache was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Dizziness postural, Headache
Clinical narrative: Disequilibrium started upon waking; Mild pain on left side of head between left eye and left ear; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 02:15 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfa allergy. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and trazodone (MANUFACTURER UNKNOWN), both for an unknown indication and from an unknown date. The patient previously took tetracycline and experienced allergy to it. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 14Apr2021 at 06:00, the patient experienced disequilibrium which started upon waking and mild pain on left side of head between left eye and left ear. More pronounced throughout the day, increased since the morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events disequilibrium started upon waking and mild pain on left side of head between left eye and left ear were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Headache
Clinical narrative: Disequilibrium started upon waking; Mild pain on left side of head between left eye and left ear; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 02:15 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfa allergy. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and trazodone (MANUFACTURER UNKNOWN), both for an unknown indication and from an unknown date. The patient previously took tetracycline and experienced allergy to it. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 14Apr2021 at 06:00, the patient experienced disequilibrium which started upon waking and mild pain on left side of head between left eye and left ear. More pronounced throughout the day, increased since the morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events disequilibrium started upon waking and mild pain on left side of head between left eye and left ear were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chest discomfort, Muscular weakness, Nerve compression, Paraesthesia
Clinical narrative: Pain along the arm; Pain in the left side of the rib cage.; Feels like tendencies in left elbow/pain in elbow; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the arm left on 02Apr2021 at 10:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient felt like tendencies in left elbow, not the usual arm pain. The patient had that for 3 days after the vaccine and again on day 9, the patient had pain in elbow. On 10Apr2021, the patient experienced pain along the arm and pain in the left side of the rib cage. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events felt like tendencies in left elbow/pain in elbow, pain along the arm and pain in the left side of the rib cage were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Musculoskeletal chest pain, Pain in extremity
Clinical narrative: Pain along the arm; Pain in the left side of the rib cage.; Feels like tendencies in left elbow/pain in elbow; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the arm left on 02Apr2021 at 10:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient felt like tendencies in left elbow, not the usual arm pain. The patient had that for 3 days after the vaccine and again on day 9, the patient had pain in elbow. On 10Apr2021, the patient experienced pain along the arm and pain in the left side of the rib cage. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events felt like tendencies in left elbow/pain in elbow, pain along the arm and pain in the left side of the rib cage were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bone pain, Hemiparesis, Hypoaesthesia, Paraesthesia
Clinical narrative: Pain along the arm; Pain in the left side of the rib cage.; Feels like tendencies in left elbow/pain in elbow; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the arm left on 02Apr2021 at 10:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient felt like tendencies in left elbow, not the usual arm pain. The patient had that for 3 days after the vaccine and again on day 9, the patient had pain in elbow. On 10Apr2021, the patient experienced pain along the arm and pain in the left side of the rib cage. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events felt like tendencies in left elbow/pain in elbow, pain along the arm and pain in the left side of the rib cage were not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort
Clinical narrative: next day pm plugged ears / pressure like when on an airplane; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder, vitiligo and rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) 150mg twice a day and vortioxetine hydrobromide (TRINTELLIX) from 20 mg once a day both for an unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:00 next day of vaccination the patient experienced  pm plugged ears / pressure like when on an airplane. No therapeutic measures were taken as a result of the events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event next day pm plugged ears / pressure like when on an airplane was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear disorder
Clinical narrative: next day pm plugged ears / pressure like when on an airplane; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder, vitiligo and rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) 150mg twice a day and vortioxetine hydrobromide (TRINTELLIX) from 20 mg once a day both for an unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:00 next day of vaccination the patient experienced  pm plugged ears / pressure like when on an airplane. No therapeutic measures were taken as a result of the events. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event next day pm plugged ears / pressure like when on an airplane was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Fatigue, Lymph node pain, Lymphadenopathy, Skin warm
Clinical narrative: small lump on the left side of my groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the net day tripled in size. It was red, hot, and very tender; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included IBS-diarrhea and was sensitive to corticosteroids which caused temporary corticosteroid glaucoma. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and prenatal vitamins; all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the day after receiving the vaccine, the patient experienced a small lump on the left side of her groin. It did not seemed to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea-sized and the next day tripled in size. It was red, hot, and very tender. After about one week it decreased in size until it healed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event small lump on the left side of groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the next day tripled in size. It was red, hot, and very tender was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site bruising, Vaccination site pain
Clinical narrative: small lump on the left side of my groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the net day tripled in size. It was red, hot, and very tender; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included IBS-diarrhea and was sensitive to corticosteroids which caused temporary corticosteroid glaucoma. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and prenatal vitamins; all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the day after receiving the vaccine, the patient experienced a small lump on the left side of her groin. It did not seemed to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea-sized and the next day tripled in size. It was red, hot, and very tender. After about one week it decreased in size until it healed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event small lump on the left side of groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the next day tripled in size. It was red, hot, and very tender was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inguinal mass
Clinical narrative: small lump on the left side of my groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the net day tripled in size. It was red, hot, and very tender; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included IBS-diarrhea and was sensitive to corticosteroids which caused temporary corticosteroid glaucoma. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and prenatal vitamins; all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the day after receiving the vaccine, the patient experienced a small lump on the left side of her groin. It did not seemed to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea-sized and the next day tripled in size. It was red, hot, and very tender. After about one week it decreased in size until it healed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event small lump on the left side of groin. It did not seem to be an ingrown hair, and seemed instead to be a swollen lymph node. It was originally pea sized and the next day tripled in size. It was red, hot, and very tender was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Discomfort, Dizziness, Nausea, Oral herpes, Pain
Clinical narrative: I felt slightly nauseous, very suddenly, accompanied by dizziness in the morning; I felt slightly nauseous; fever blisters began erupting all around mouth/very painful; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 06Apr2021 at 18:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. It was reported that the patient had unspecified allergies to medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 16Mar2021 at 18:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 08:00, the patient felt slightly nauseous, very suddenly, accompanied by dizziness in the morning, it passed after 20 minute or so at 08:20. On 13Apr2021, on the same day, the patient had fever blisters began erupting all around mouth which were very painful, and unsightly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event dizziness and nauseous was recovered on 13Apr2021 at 08:20 and the clinical outcome of the event fever blisters was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Nausea, Oral herpes
Clinical narrative: I felt slightly nauseous, very suddenly, accompanied by dizziness in the morning; I felt slightly nauseous; fever blisters began erupting all around mouth/very painful; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 06Apr2021 at 18:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. It was reported that the patient had unspecified allergies to medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 16Mar2021 at 18:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 08:00, the patient felt slightly nauseous, very suddenly, accompanied by dizziness in the morning, it passed after 20 minute or so at 08:20. On 13Apr2021, on the same day, the patient had fever blisters began erupting all around mouth which were very painful, and unsightly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event dizziness and nauseous was recovered on 13Apr2021 at 08:20 and the clinical outcome of the event fever blisters was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 12Apr2021 at 13:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history reported. The patient had no known allergies to medications, food, or other products. Concomitant medication included cetirizine hydrochloride (ZYRTEC) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 22Mar2021 at 13:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 13:30, the patient experienced vertigo. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event vertigo was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; some pain in underarm of left arm; chills; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history includes COVID-19 and allergies to adhesive on lg bandaids. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), apoaequorin (PREVAGEN) and zinc (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if onging. The patient previously received chlorhexidine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 14:00, the patient experienced fever and chills. some pain in underarm of left arm. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, some pain in underarm of left arm and chills were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Pyrexia
Clinical narrative: fever; some pain in underarm of left arm; chills; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history includes COVID-19 and allergies to adhesive on lg bandaids. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), apoaequorin (PREVAGEN) and zinc (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if onging. The patient previously received chlorhexidine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 14:00, the patient experienced fever and chills. some pain in underarm of left arm. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, some pain in underarm of left arm and chills were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Laboratory test normal, Nausea
Clinical narrative: Tired; Brain Fogg; Dizzy; Nausea within first 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease and bipolar. Concomitant medications included temazepam (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), cetirizine (MANUFACTURER UNKNOWN) and unspecified vitamin; all for unknown indication from unknown date  and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 31Mar2021, the patient experienced nausea within first 15 minutes of vaccination. On 01Apr2021 at 12:00, the patient experienced tired, brain fog and dizzy. The events persisted for more than 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tired, brain fog and dizzy and included treatment with meclizine. The clinical outcome of the event nausea was recovered on 31Mar2021, subsided 2 to 3 hours later. The clinical outcome of the event tired, brain fog and dizzy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Tired; Brain Fogg; Dizzy; Nausea within first 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease and bipolar. Concomitant medications included temazepam (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), cetirizine (MANUFACTURER UNKNOWN) and unspecified vitamin; all for unknown indication from unknown date  and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 31Mar2021, the patient experienced nausea within first 15 minutes of vaccination. On 01Apr2021 at 12:00, the patient experienced tired, brain fog and dizzy. The events persisted for more than 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tired, brain fog and dizzy and included treatment with meclizine. The clinical outcome of the event nausea was recovered on 31Mar2021, subsided 2 to 3 hours later. The clinical outcome of the event tired, brain fog and dizzy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Nausea
Clinical narrative: Tired; Brain Fogg; Dizzy; Nausea within first 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease and bipolar. Concomitant medications included temazepam (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), cetirizine (MANUFACTURER UNKNOWN) and unspecified vitamin; all for unknown indication from unknown date  and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 16:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 31Mar2021, the patient experienced nausea within first 15 minutes of vaccination. On 01Apr2021 at 12:00, the patient experienced tired, brain fog and dizzy. The events persisted for more than 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tired, brain fog and dizzy and included treatment with meclizine. The clinical outcome of the event nausea was recovered on 31Mar2021, subsided 2 to 3 hours later. The clinical outcome of the event tired, brain fog and dizzy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.